CTLA4 and neoplasm: Furthermore, we double checked the anti-tumor effect of the CTLA-4 antibody treatment by measuring the differences in tumor growth in the same tumor type and then isolated the tumor tissue and characterized it by immunohistochemistry to further validate the immune microenvironment mechanism after therapy [17–19].